Sirona Biochem Corp
OTC:SRBCF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sirona Biochem Corp
OTC:SRBCF
|
CA |
|
W
|
Wavus Co Ltd
KOSDAQ:336060
|
KR |
|
H
|
Hanla IMS Co Ltd
KOSDAQ:092460
|
KR |
Intrinsic Value
The intrinsic value of Sirona Biochem Corp (SRBCF) under the Base Case is 0.007 USD per share. Compared with the current market price of 0.0051 USD, the stock appears Undervalued by 27% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Sirona Biochem Does
Sirona Biochem Corp. engages in development of cosmetic ingredient and drug. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2007-07-10. The firm developed its technology platform at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. Its principal activities are dedicated to the development of cosmetic and pharmaceutical active ingredients which are partners in exchange for payments.
- Headquarters
- Canada CA
- IPO date
- Jul 10, 2007
Earnings Waterfall
Sirona Biochem Corp
The intrinsic value for Sirona Biochem Corp (SRBCF) under the Base Case is 0.007 USD.
Compared with the current market price of 0.0051 USD, the stock appears Undervalued by 27% .